(public).sospep.subjects ~ view article ~ how-gut-bacteria-are-shaking-up-cancer-research

<h1 style="text-align: center;">How Gut Bacteria Are Shaking Up Cancer Research</h1>
<h1 style="text-align: center;">&nbsp;</h1>
<h2>[WHAT]</h2>
<ol>
<li>&nbsp;] by Makiko Kitamura @ bloomberg.com - Top scientists at Roche Holding AG and AstraZeneca Plc are sizing up potential allies in the fight against cancer: the trillions of bacteria that live in the human body.</li>
</ol>
<h2>[WHY]</h2>
<ol>
<li>]&nbsp;</li>
</ol>
<h2>[WHERE]</h2>
<ol>
<li><strong>] READ THE FULL ARTICLE</strong></li>
<ol>
<li>]&nbsp;<a href="http://www.bloomberg.com/news/articles/2016-03-14/how-gut-bacteria-are-shaking-up-cancer-research" target="_blank">How Gut Bacteria Are Shaking Up Cancer Research&nbsp;</a>(bloomberg.com)</li>
</ol></ol>
<h2>[WHEN]</h2>
<ol>
<li>] 2016-03-15</li>
</ol>
<h2>[EXAMPLE - auto. summary by smmry.com]</h2>
<ol>
<li>] Top scientists at Roche Holding AG and AstraZeneca Plc are sizing up potential allies in the fight against cancer: the trillions of bacteria that live in the human body.</li>
<li>] "Five years ago, if you had asked me about bacteria in your gut playing an important role in your systemic immune response, I probably would have laughed it off," Daniel Chen, head of cancer immunotherapy research at Roche's Genentech division, said in a phone interview.</li>
<li>] That's increased drugmakers' interest in the human microbiome - the universe of roughly 100 trillion good and bad bacteria, fungi and viruses that live on and inside the body.</li>
<li>] Roche is already undertaking basic research in the field and plans to investigate the microbiome's potential for cancer treatment, Chen said.</li>
<li>] The promise in cancer will draw more large drugmakers into exploring the human microbiome, said Bernat Olle, chief executive officer of Vedanta Biosciences, a Boston-based startup.</li>
<li>] Studies have shown that immunotherapies have varying degrees of success even in genetically identical mice, and the Science study from Chicago suggests that the diversity of the microbiome may help explain that variability, Galbraith said.</li>
<li>] The sheer number of bacteria, some of which could actually switch off an immune response, and the question of how much bacteria is needed, make it a complex area of research, Roche's Chen said.</li>
</ol>
<h2>[HOW-TO]</h2>
<ol>
<li>]&nbsp;</li>
</ol>
<h2>[REFERENCE]</h2>
<ol>
<li>] SRC = HN, <a href="https://news.ycombinator.com/item?id=11282054" target="_blank">comments</a></li>
</ol>
<h1 style="text-align: center;">&nbsp;</h1>

~ view article ~ Chapter] index-health-research FROM [ Book] research IN [ libraries] health